VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
1-Year Return
12.28%
This Quarter Return
-16.95%
1 Year Return
-12.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.4B
AUM Growth
-$286M
(-17%)
Cap. Flow
-$95.2M
Cap. Flow
% of AUM
-6.8%
Top 10 Holdings %
Top 10 Hldgs %
51.45%
Holding
86
New
13
Increased
27
Reduced
13
Closed
23
Top Buys
| 1 |
Arcellx
ACLX
|
+$125M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$50.3M |
| 3 |
Scholar Rock
SRRK
|
+$41.8M |
| 4 |
Vera Therapeutics
VERA
|
+$34.2M |
| 5 |
Nuvalent
NUVL
|
+$33.7M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$120M |
| 2 |
Merck
MRK
|
+$79.6M |
| 3 |
Ascendis Pharma
ASND
|
+$57.6M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$56.5M |
| 5 |
Soleno Therapeutics
SLNO
|
+$47.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Neurogene
NGNE
$278M
| – | – |
-80,000
| Closed | -$1.83M |
|
77
Intellia Therapeutics
NTLA
$1.28B
| – | – |
-525,000
| Closed | -$6.12M |
|
78
Regeneron Pharmaceuticals
REGN
$59B
| – | – |
-20,000
| Closed | -$14.2M |
|
79
Roivant Sciences
ROIV
$8.82B
| – | – |
-1,250,000
| Closed | -$14.8M |
|
|
80
Soleno Therapeutics
SLNO
$3.84B
| – | – |
-1,060,000
| Closed | -$47.6M |
|
81
Sanofi
SNY
$116B
| – | – |
-750,000
| Closed | -$36.2M |
|
82
Transmedics
TMDX
$3.69B
| – | – |
-50,000
| Closed | -$3.12M |
|
|
VERV
83
DELISTED
Verve Therapeutics
VERV
| – | – |
-645,000
| Closed | -$3.64M |
|
84
Zai Lab
ZLAB
$3.49B
| – | – |
-300,000
| Closed | -$7.86M |
|
|
CMRX
85
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-1,400,000
| Closed | -$4.87M |
|
|
ACHL
86
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| – | – |
-1,500,000
| Closed | -$1.71M |
|